Pharmaceuticals & Biotechnology Editor | 03/25/2010
Eli Lilly and Co. is a leader in researching and developing pharmaceutical-based healthcare solutions that enable patients to live longer, healthier and more active lives. In the five years from 2001 to 2005, when FDA approved nearly 40 percent fewer new molecular entities than it did in the preceding five-year period, Lilly has launched nine new products.
Download PDF Attachment
RECOMMENDED
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 1 - 3 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
GenAI Life Science & Health 2025
September 1 - 3 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More